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Analysis of repetitive element 
expression in the blood and skin of 
patients with parkinson’s disease 
identifies differential expression of 
satellite elements
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& pille taba3
Repetitive elements (Re) constitute the majority of the human genome and have a range of functions 
both structural and regulatory on genomic function and gene expression. Re overexpression has 
been observed in several neurodegenerative diseases, consistent with the observation of aberrant 
expression of Re posing a mutagenic threat. Despite reports that associate Re expression with pD no 
study has comprehensively analysed the role of these elements in the disease. this study presents the 
first genome-wide analysis of RE expression in PD to date. Analysis of RNA-sequencing data of 12 PD 
patients and 12 healthy controls identified tissue-specific expression differences and more significantly, 
differential expression of four satellite elements; two simple satellite III (repName = CAttC_n and 
_GAATG_n) a high-copy satellite II (HSATII) and a centromeric satellite (ALR_Alpha) in the blood of PD 
patients. In support of the growing body of recent evidence associating REs with neurodegenerative 
disease, this study highlights the potential importance of characterization of Re expression in such 
diseases.
Parkinson’s disease (PD) is the second most common progressive neurodegenerative condition1, with late-onset 
forms of PD affecting around 3–4% of individuals over the age of 802,3. It is characterized pathologically by the 
degeneration and loss of the dopaminergic neurons in the substantia nigra and the presence of a-synuclein aggre-
gates called Lewy bodies in the central nervous system (CNS)3,4. However recent studies have associated more 
widespread involvement of other CNS structures and peripheral tissue with the disease etiology5–9.
Despite huge successes in identifying genetic mutations and risk factors associated with PD, to date there has 
been little success in developing definitive diagnostic and prognostic biomarkers for the disease. The only defin-
itive diagnosis for PD is performed post-mortem. As onset of the molecular and cellular neuropathology seen in 
PD likely initiates decades before the manifestation of the motor symptoms, the need for developing a diagnostic 
marker in readily available tissue is urgent, not only for early intervention but also to monitor progression of 
therapeutic treatments10. Recent efforts have focused on identifying biomarkers of PD in peripheral tissues, with 
studies identifying molecular alterations in the blood and skin of PD patients. Notably the transcriptional profile 
from the blood and skin of PD patients demonstrated dysregulation of genes known to be associated with PD11–13.
Repetitive element (RE) sequence constitutes the majority of the human genome. Recently the field have seen 
the development of more sophisticated bioinformatic methods, that can now accurately analyze RE expression 
1Department of Molecular and clinical Pharmacology, institute of translational Medicine, University of Liverpool, 
Liverpool, UK. 2Department of Pathophysiology, University of tartu, tartu, estonia. 3Department of neurology, 
University of tartu, tartu, estonia. 4faculty of Medicine, University of tartu, tartu, estonia. 5estonian Defense forces, 
tartu, estonia. 6Perron institute for neurological and translational Science, Sarich neuroscience Research institute, 
8 Verdun St, Nedlands, 6009, Western Australia, Australia. 7centre for comparative Genomics, Murdoch University, 
Murdoch, 6150, Western Australia, Australia. Kimberley J. Billingsley and Freddy Lättekivi contributed equally. 
Correspondence and requests for materials should be addressed to S.K. (email: sulev.koks@perron.uwa.edu.au)
Received: 21 September 2018
Accepted: 22 February 2019
Published: xx xx xxxx
OPEN
2Scientific RepoRts |          (2019) 9:4369  | https://doi.org/10.1038/s41598-019-40869-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
ans this has led to the role of RE in disease etiology becoming increasingly apparent. RE can be broadly split into 
five categories each of which, have very distinct functions. The first four minor categories account for ~10% of 
the genome, and include; simple sequence repeats, segmental duplications, tandem repeats and satellite DNA 
sequences, and processed pseudogenes. The fifth and most major and abundant group of RE are transposable 
elements (TE)s14.
TEs constitute ~45% of the human genome and can be subdivided based on their method of replication, i.e via 
an RNA (retrotransposable elements (RTEs)) or DNA (DNA transposons) intermediate. RTEs are further clas-
sified into long terminal repeats (LTR) or non-(LTR) elements. The later resemble integrated mRNAs and have 
a distinct mechanism of retrotransposition. Non-LTR RTE have also been associated with a number of diseases 
and can be classified as either long interspersed nuclear elements (LINEs) or short interspersed nuclear elements 
(SINEs)14. For a detailed review of the impact of RTE in the human genome and their role in disease see15 and an 
overview the classification of RE is shown in (Fig. 1).
Dysregulation of RTEs has been associated with several neurological disorders and increased expression 
is linked with toxicity and genomic instability16–19. In response to this, cells have developed various epigenetic 
mechanisms to ensure RTEs are tightly suppressed. However it would appear this mechanism goes awry in 
pathological state, with increased RTE expression being reported in conditions such as schizophrenia, Rett syn-
drome, Creutzfeldt-Jakob disease (CJD), ataxia telangiectasia and many cancers20–22. Specifically, accumulation 
of RTE transcripts has been described in several neurodegenerative diseases such as Alzheimer’s disease (AD) 
and Amyotrophic lateral sclerosis(ALS)16–18,23. A more relevant example of the potential toxicity of RTEs has been 
highlighted in a recent PD related study, which focussed on assessing the role of LINE1 (a non-LTR, LINE RTE 
element) in mesencephalic dopaminergic neurons. In an Engrailed-1 heterozygote model Blaudin de The show 
that LINE1 RNA upregulation correlates with increased DNA damage and cell death induced by oxidative stress. 
Subsequently reduction of LINE1 protects against oxidative stress in vitro and in vivo24.
Despite the growing body of evidence that shows that RE expression is associated with many diseases, 
genome-wide expression of these elements is yet to be characterized in PD. In this study, we utilized existing 
RNA-Seq data from the skin12 and blood of the same individuals and characterized RE expression in both PD 
patients and healthy controls. To gain novel insight into the expression of all classes of RE, unlike other methods 
that focus only on RTN, we utilized the well-established RepEnrich pipeline that quantifies all known RE class 
sequences. We report that overall REs are widely expressed in both tissues, with observed tissue-specific differ-
ences and most significantly, that two simple satellite III (repName = CATTC_n and _GAATG_n), a high-copy 
satellite II (repName = HSATII) and a centromeric satellite element (repName = ALR_Alpha) were differentially 
expressed in the blood in PD.
Results
Repetitive elements are widely expressed in the blood and skin. Analysis of RNA-Seq data from 
12 PD patients and 12 controls (with an average of 24 (blood) or 31 (skin) million reads per individual) identified 
that 20.3% (blood) and 23.8% (skin) of reads mapping to the reference genome GRCh37/hg19 aligned to the 
RE annotated in the RepeatMasker GRch37/hg19 Library (Fig. 2). No significant bias was detected in the RNA-
Seq datasets by visualizing the read counts for expressed genes as principal component analysis (PCA) plots 
(Supplementary Figs S1–S4). REs were widely expressed, on average of the 1117 REs queried, 1086 were detected 
in the blood (RPKM ≥1)(97%) and 1099 in the skin. Based on RepeatMasker annotations RepEnrich output is 
quantified into three categories 1) expression of every RE that has a known consensus sequence in RepeatMasker, 
which is named as ‘subfamily’ classification (n = 1117) 2) grouping all of the REs by ‘family’ (n = 48) and 3) fur-
ther sub grouping of the families by ‘class’ (n = 13). An explanation of the grouping of the RepEnrich output for 
expression levels is given in (Supplementary Table 1). No significant difference for relative abundance of reads 
Figure 1. Repetitive DNA classes in the human genome. The major class of RE are Transposable elements, 
which can be further divided into DNA transposons or Retrotransposons according to there mechanism of 
transposition, i.e through a RNA or DNA intermediate. Retrotransposons are the most abundant class in the 
human genome and can be further divided into long terminal repeats (LTR) and non –LTR retrotransposons. 
Non-LTR elements have the ability to mobilise and can be further subdivided into SINE (e.g. Alu elements) and 
LINE (e.g. LINE1 elements). The LTR class of RTE contains endogenous retroviruses (ERVs) such as HERV-K.
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originating from each of the different RE classes was observed between PD and control in the blood or in the skin 
(Supplementary Table 2).
Of the reads that mapped to the RE pseudogenome assembly, in the blood on average 37.10% originated 
from LINE elements, 31.22% from SINE, 13.93% from LTR, 10.41% from rRNA, 6.90% from DNA and 0.44% 
other (satellite, snRNA, tRNA, RNA, RC, scRNA). In the skin on average 35.71% originated from LINE ele-
ments, 26.47% from SINE, 14.70% from LTR, 13.14% from rRNA, 9.41% from DNA and 0.57% other (satellite, 
snRNA, tRNA, RNA, RC, scRNA) (Fig. 2). However when the abundance of individual members of each class 
were compared between the two tissues analyzed, there were significant differences in relative abundance of RE 
between blood and skin for the majority of the classes, highlighting previously reported tissue-specific nature of 
RE expression25.
Satellite elements are significantly upregulated in the blood of PD patients. EdgeR analysis 
was applied to compare RE expression between PD patients and healthy control subjects in both the blood and 
skin. The edgeR-normalized pseudocounts of REs were visualized on PCA plots and no possible biases affecting 
the analysis were observed (Supplementary Figs S1 and S2). No significant differences in RE expression were 
observed comparing PD patients and healthy controls in the skin (FDR ≤ 0.01). However, upregulation of satellite 
REs at the class level with a log2FC increase of 1.93 (FDR = 7.7E-06) was identified in the blood from PD patients 
compared to the blood from healthy control subjects (Supplementary Table 3).
At the family level, 3 RE families were significantly differentially expressed at FDR ≤ 0.01; satellite, centr and 
acro (FDR = 7.88E-06, 7.88E-06, 6.39E-04 respectively), which were upregulated with a logFC increase of 2.05 for 
satellite, 1.84 for centr and 1.30 for acro in the blood from the PD patients (Supplementary Table 4).
Figure 2. Mapped repetitive element expression in the blood and skin. Analysis of RNA-Seq data from the 
blood of 12 PD patients and 12 controls (with an average of 24 (blood) or 31 (skin) million reads per individual) 
identified 20% of reads mapping to the reference genome GRCh37/hg19, aligned to the custom built RE 
psuedogenome assembly used in RepEnrich. Of the reads that mapped to the RE pseudogenome assembly, in 
the blood on average 37.10% originated from LINE elements, 31.22% from SINE, 13.93% from LTR, 10.41% 
from rRNA, 6.90% from DNA and 0.44% other (satellite, snRNA, tRNA, RNA, RC, scRNA). In the skin on 
average 35.71% originated from LINE elements, 26.47% from SINE, 14.70% from LTR, 13.14% from rRNA, 
9.41% from DNA and 0.57% other (satellite snRNA, tRNA, RNA, RC, scRNA).
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At the subfamily level four specific satellite class REs were significantly differentially expressed at FDR ≤ 0.01, 
two simple satellite IIIs (repName = CATTC_n and _GAATG_n) a high-copy satellite II (repName = HSATII) 
and a centromeric satellite (repName = ALR_Alpha) all of which were upregulated in the blood of PD patients 
(Appendix.1. Supplementary data) (Table 1). Moreover, the expression levels of the aforementioned satellite ele-
ments displayed little inter-variability in the PD patient group when compared to healthy controls (Fig. 3).
Simple satellite III repeat (CATTC)n RNAs were the most significantly upregulated in PD blood 
(p-value = 2.27E-12) with a logFC increase of 4.40. Pericentromeric human satellite II (HSATII) repeat derived 
RNAs were also significantly upregulated (p-value = 2.79E-12) with a logFC increase of 4.12. HSATII derived 
RNA should be undetectable in normal tissue and dysregulation of these elements has shown to induce genomic 
instability26. Simple satellite III (GAATG)n derived RNAs were also upregulated in the blood of PD patients 
compared to the blood of healthy control subjects (p-value = 1.68E-11) with a logFC increase of 4.23. Finally, 
human alpha centromeric satellite (ALR_Alpha) derived RNAs were also upregulated in the blood of PD patients 
compared to the blood of healthy control patients (p-value = 5.20E-08) with a 2.02 logFC increase (Fig. 3).
Class Family RE Description Log FC Log CPM P-value FDR
Satellite Satellite _CATTC_n Simple satellite III 4.4 7.74 2.27E-12 1.56E-09
Satellite — HSATII High-copy satellite II 4.12 5.69 2.79E-12 1.56E-09
Satellite Satellite _GAATG_n Simple satellite III 4.23 7.32 1.68E-11 6.25E-09
Satellite Centromeric ALR_Alpha 171 bp satellite associate with human centromeres 2.02 8.69 5.20E-08 1.45E-05
Table 1. Differentially expressed repetitive elements identified in blood from PD patients. Showing 
characteristics of each differentially expressed element, log FC, log CPM, p-value and FDR (≤0.01 cut off).
Figure 3. Upregulation of Satellite elements in the blood of PD patients. At the subfamily level four satellite 
class repetitive elements were significantly differentially expressed at FDR ≤ 0.01, two simple satellite III 
(repName = CATTC_n and _GAATG_n) a high-copy satellite II (repName = HSATII) and a centromeric 
satellite (repName = ALR_Alpha) all of which were upregulated in the blood of PD patients. Simple satellite III 
repeat (CATTC)n RNAs were the most significantly upregulated in the blood of PD patients (p-value = 2.27E-
12) with a logFC increase of 4.40. Pericentromeric human satellite II (HSATII) repeat derived RNAs were 
significantly upregulated (p-value = 2.79E-12) with a logFC increase of 4.12. Simple satellite III (GAATG)n 
derived RNAs were upregulated in PD (p-value = 1.68E-11) with a logFC increase of 4.23. Finally, human alpha 
centromeric satellite (ALR_Alpha) derived RNAs were also upregulated in PD (p-value = 5.20E-08) with a 2.02 
logFC increase.
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Discussion
This study presents the first genome-wide analysis of RE expression in PD, this analysis also included a 
detailed characterization of the expression of REs in the blood and skin and highlights the previously reported 
tissue-specific nature of RE expression25,27. Using a stringent FDR cut-off of 0.01 we found that there was no 
differential expression of REs in the skin when PD patients and healthy controls were compared. However in the 
blood we identified that satellite elements are upregulated in PD patients and most significantly that a group of 
satellite elements, (repName = CATTC_n, HSATII, ALR_Alpha) which are a group of elements that have been 
collectively associated with genome instability26,28, are significantly differentially expressed.
Characterization of RNA-Seq data in the 24 subjects studied identified that REs were widely expressed and 
constituted 20% of all expressed transcripts in the blood and 24% of all expressed transcripts in the skin. We 
report no significant difference in relative abundance of global RE expression between patients versus controls 
for either tissue (Supplementary Table 2). Our data is in agreement with that reported by Faulkner et al. who per-
formed a comprehensive RE analysis using cap analysis gene expression (CAGE) sequencing data and determined 
that in human tissue, on average around 20% of all CAGE tags detected were mapped to REs and overall RE 
expression varied significantly between tissue25. Our data is also supported by a recent study from our group that 
analyzed skin RNA-Seq data from 12 individuals with psoriasis and 12 healthy controls with the same RepEnrich 
pipeline and found that on average 27.5% of reads aligned to REs27.
In light of the recent associations between RTE dysregulation and neurodegenerative disease, more specifically 
the identification of LINE1 overexpression inducing death of mesencephalic dopaminergic neurons, we set out 
to identify if these elements were differentially expressed in the peripheral tissues of PD patients. Our analysis 
used a method that not only determined differential expression of the different classes of RTEs but all class of RE. 
Although we did not observe differentially expressed RTEs in the skin or blood of PD patients, we did identify 
upregulation of satellite elements in the blood of PD patients(Table 1, Fig. 3).
Overall aberrant overexpression of satellite repeats has been associated with genomic instability29,30. 
Collectively three of the upregulated satellite elements identified in this study (repName = CATTC_n and _
HSATII and ALR_Alpha) have been named as a group of REs involved in genomic instability and considered 
to be transcriptionally silent in the genome26. Although the simple satellite III RE (repName = _GAATG_n) was 
also significantly upregulated, like many of the REs, there is a paucity of information available for the function 
of this RE in the literature. Interestingly, in addition to increased expression levels, a considerably small degree 
of variability was observed in the PD patients compared to the healthy control subjects. This could hint at a yet 
undetermined regulatory process that can be associated with PD pathophysiology.
Studies have shown that inducing dysregulation of genes known to silence satellite elements can promote 
genomic instability, which consequently can result in; growth arrest, impaired homologous recombination and 
spontaneous DNA breaks through this pathway. An example of this is apparent with the gene SIRT1 (Silent infor-
mation regulator-1) which is a known repressor of repetitive DNA. It has been shown in mouse ES cells that when 
SIRT1 is inhibited one of the major consequences is activation of major satellite repeats and thus an increase in 
expressed satellite transcripts is observed31. This process has been associated with mitochondrial dysfunction 
and oxidative stress, which are common pathways that are affected during ageing and that have been implicated 
in PD32. However, it is unknown if the observed upregulation of satellite elements is a mechanistically important 
factor in the etiology of PD or if it is simply an indicator of pathophysiological state; thus, it will of interest in the 
future whether such pathways and genes are modulated in the CNS or in immune cells in PD. As shown in Fig. 3 
there is a striking loss of variability in the expression of the group of satellite elements upregulated in PD, which 
is pattern that is not observed in other RE elements (Supplementary Fig. S5). Therefore our data indicates that 
overexpression of these specific satellite elements is a potential disease-specific signature in the blood for PD and 
highlights the need for further characterization of our model in a larger, better clinically defined, data sets to also 
address if there is possible association with progression of the disease.
We set out to characterise RE expression with previously published PD RNA-Seq data in response to recent 
studies that have associated RTE expression with neurodegenerative disease. This type of analysis has not been 
explored previously, mainly due to the lack of technology to do so. Using a tool that not only quantifies RTE 
expression but all class of REs we report that a group of satellite elements are differentially expressed and appear 
to have a PD specific expression signature in the blood. Although we report the first genome-wide analysis of RE 
expression in PD to date, our study does have a number of limitations. First, we acknowledge that the cohort size 
(n = 24) is particularly small. By showing that there are significant disease-specific signatures of RE expression, 
we hope to illustrate that RE expression should be addressed when larger PD expression data-sets are available. 
Another limitation is that we show through of our analysis (of the blood and skin of the same individuals) that 
RE expression occurs in a tissue specific manner. Thus we cannot make any presumptions that this reflects what 
could be happening in the brain. Although a very interesting concept, addressing RE expression in the brains of 
PD individuals is particularly problematic as the areas of interest will have occured alot of cell-death at time of 
post-mortem. Despite the literature suggesting a possible role of RTE in the brain and neurodegeneration in par-
ticular, the purpose of our present study was to look for possible differences in RE expression in readily available 
tissue (such as blood and skin) as a possible biomarker.
Conclusion
In summary, the field is still far from establishing the molecular mechanisms underpinning PD and much pro-
gress is needed to develop an objective biomarker for the disease. We utilized previously existing RNA-Seq data 
and characterized RE expression in the blood and skin of PD patients, our rationale being, 1) recent studies 
have shown that disease pathology can be detected in the peripheral tissue 2) more sophisticated bioinformatic 
methods have provided a growing body of evidence that RTE dysregulation is associated with neurodegenerative 
diseases such as AD,ALS and PD16,17,23,24. We identified firstly, overall tissue-specific differences in RE expression 
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as supported by the literature and secondly that a specific group of satellite elements, that have been strongly 
associated with epigenetic instability, displayed altered expression in the blood of patients with PD. Although we 
cannot comment on whether the observed upregulation of satellite elements is a mechanistically important factor 
in the etiology of PD or simply an indicator of a pathophysiological state, this data does support recent studies 
showing that PD pathogenesis can be linked with changes in the peripheral tissue12,13. Further characterization is 
required to determine the consequence of upregulation of satellite elements in PD, however our data supplies a 
potential novel non-invasive biomarker of the disease and its progression
Methods
study participants and ethics. Blood samples were collected from 12 patients with PD (6 men and 6 
women, aged 72.2 ± 9.9 years, mean ± SD), and 12 healthy control subjects (blood; 6 men and 6 women, aged 
68.9 ± 6.9 years, skin). All patients fulfilled the Queen Square Brain Bank Criteria for idiopathic PD33,34. The mean 
onset age and duration of disease at sample collection were 65.5 ± 8.6 and 7.3 ± 6.3 years, respectively (Table 2). A 
detailed description of individuals enrolled on the skin study please refer to Planken et al.12. In brief, the median 
total score of the Movement Disorder Society sponsored revision of the Unified Parkinson Disease Rating Scale 
(MDS-UPDRS)35 was 65 (ranging from 22 to 159). The median disease severity assessed by the Hoehn and Yahr 
scale36 was 2.75 (ranging from 1 to 4). The median disability score assessed by the Schwab and England Activities 
of Daily Living Scale (SE-ADL) was 80% (ranging from 40% to 100%). None of the PD patients were current 
smokers and two had a history of smoking in the past.
The study was approved by the Research Ethics Committee of the University of Tartu. Volunteer PD patients 
and healthy controls were recruited from the Department of Neurology and Neurosurgery at the University 
Hospital of Tartu. A signed informed consent was acquired from all subjects participating in this study.
Library preparation. The venous blood of all study subjects was collected into Tempus Blood RNA Tubes 
(Thermo Fisher Scientific Inc, CA, USA). The RNA was extracted applying Tempus Spin RNA Isolation Kit 
(Thermo Fisher Scientific Inc, CA, USA) combined with DNase treatment (RNase-Free DNase Set, Qiagen, 
Hilde, Germany), according to the manufacturer’s’ protocols. The globin mRNA was removed from the extracted 
total RNA using GLOBINclear Kit for human (Thermo Fisher Scientific Inc, CA, USA). For the skin, one 4 mm 
punch-biopsy specimen was taken from non- sun-exposed skin of each subject from both study groups. All 
biopsy specimens were instantly frozen in liquid nitrogen and stored at −80 °C until RNA extraction. Biopsies 
were homogenized with Precellys24 homogenizer with the Cryolys system (Bertin Technologies). RNeasy Fibrous 
Tissue Mini Kit (Qiagen, Hilde, Germany) was used for total RNA extraction, according to the manufacturer’s 
protocol. During the purification on-column DNase I treatment was performed (Qiagen Hilde, Germany). The 
RNA quality was assessed using Agilent 2100 Bioanalyzer, with the RNA 6000 Nano kit (Agilent Technologies) 
and the quantity was evaluated with Qubit fluorometer and Qubit RNA HS Assay kit (Life Technologies). The 
study samples RIN ranged from 6.7–9.5 in the blood and skin samples.
RNA sequencing. 50 ng of each RNA sample was amplified with Ovation RNA-Seq System V2 Kit (NuGen 
Technologies Inc, CA, USA) and the output double stranded DNA was used to prepare SOLiD 5500 W System 
DNA fragment libraries according to manufacturer’s protocols (Thermo Fisher Scientific Inc, CA, USA). For 
library preparation, the barcoding adapters were used, and 12 libraries were pooled prior to sequencing. For 
sequencing skin samples, the SOLiD 5500 W XL with paired-end chemistry (75 bp in forward and 35 bp in reverse 
direction) in 6-lane mode was applied. In the case of blood samples SOLiD 5500 W XL platform with fragment 
sequencing chemistry (75 bp in forward directions) in 3-lane mode was used. In both cases approximately 40 mil-













M 85 67 18 3 4 40 27
M 76 75 1 1 2.5 90 30
M 73 65 9 2 3 80 30
M 67 50 17 2 4 70 28
M 69 68 2 3 3 80 30
M 73 72 1 1 1 95 29
F 82 74 9 3 4 60 26
F 68 65 4 1 1.5 100 30
F 71 66 6 2 3 70 24
F 48 47 2 2 1.5 90 30
F 69 67 3 1 2.5 80 29
F 85 70 15 1 2.5 60 23
Table 2. Characteristics of the PD patients: HY = Hoehn and Yahr stage; SE-ADL, Schwab and England 
Activities of Daily Living Scale; MMSE, Mini Mental State Examination. *1-tremor-dominant; 2-akinetic-rigid; 
3-postural instability and gait disorder.
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Read alignment and quantification. Raw color-space reads were filtered for rRNA, active tRNA, and 
SOLiD adaptor sequences. The remaining reads were aligned as single-end reads to the GRCh37/hg19 refer-
ence genome, while allowing multi-mapping to detect reads aligning to possible repeat sequences. To ensure 
secondary alignments were reported in the BAM files no mapping quality cut-off was set. LifeScope software 
(LifeTechnologies) with recommended settings designed for color-space read alignment and analysis was used 
for both mapping steps.
The number of reads aligning to known exonic gene sequences were counted and visualized by plotting the 
first two principal components in order to exclude the possibility of bias in the RNA-seq datasets. The base Stats 
package in R was used to conduct the principle component analysis (PCA)37. Prior to PCA, the read counts were 
normalized as z-scored counts per million mapped reads (CPM) values, where the standard deviation and mean 
were calculated separately for each gene. PCA plots are shown in (Supplementary Figs S1–S4).
To connect color-space mapping with the RepEnrich pipeline https://github.com/nskvir/RepEnrich14, the 
GRCh37/hg19 mapped BAM files were parsed using samtools and in-house perl scripts to separate unique and 
non-unique mapped reads. For uniquely mapped reads, only alignments with MAPQ ≥ 10 (in Phred scale) were 
retained, on average ~77% of all reads mapped to the reference genome. For multi-mapping reads, the base-space 
sequence was inferred from the longest alignment and these reads were converted to FASTQ format. This enabled 
us to convert the color-space data into suitable format for downstream analysis. RepEnrich with default param-
eters was applied to obtain read counts of REs RepEnrich aligns multi-mapping reads separately to a pseudog-
enome containing the RE loci lifted from the RepeatMasker GRch37/hg19 Library in order to more accurately 
infer read counts which reflect the abundance of expressed RE.
Analysis of differentially expressed repetitive elements. The R package edgeR (Robinson et al. 2010) 
was used to identify differentially expressed REs at sub-family, family and class level between the case and control 
in the blood and skin. The EdgeR package uses a negative binomial model to infer the significance of differential 
read counts.The RE overall library sizes were used for normalization of read counts for each sample. Prior to 
differential expression testing, the edgeR-normalized RE pseudocounts were visualized by plotting the first two 
principal components in order to check for potential bias in the RE counts data. The generalized linear model 
approach of EdgeR was then applied to compare PD to control. The workflow used for the RepEnrich analysis is 
outlined in (Fig. 4).
ethics approval and consent to participate. The study was conducted in accordance with the 
Declaration of Helsinki and approval was granted by the Tartu University Ethics Committee. Informed consent 
was obtained from all patients and controls.
Data Availability
The data supporting the conclusions of this article and raw counts from the RepEnrich output are included within 
this article and its supplementary information.
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